Appili Therapeutics Inc. (APLI) Fundamentals

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.
SHARE INFORMATION
Market Cap$ 6,061,306
Shares Outstanding121,266,120
Float107,523,990
Percent Float88.7%
Short Interest88,034.00
Short Percent Float100.0%
Short Interest Ratio0.765773
Short Interest Date2022-09-15
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,390,684
Latest Fiscal EPS$ -0.38
Latest Fiscal Date2022-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions-
Institutional Holdings Date-
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned13,702,130
TRADING INFO
52 Week High$ 1.14
52 Week Low$ 0.05
52 Week High Change$ -94.74
21 Day Moving Average$ 0.06119
21 Day Extended Moving Average$ 0.060132
50 Day Moving Average$ 0.0644
50 Day Extended Moving Average$ 0.064986
200 Day Moving Average$ 0.0947
200 Day Extended Moving Average$ 0.177196
10 Day Average Volume162,224
20 Day Average Volume117,159
30 Day Average Volume94,369
50 Day Average Volume99,332
Alpha-0.016284
Beta0.918036
Standard Deviation0.322646
R20.018898
7 Day Price Change$ -0.01
7 Day Percent Change-16.67%
21 Day Price Change$ -0.01
21 Day Percent Change-16.67%
30 Day Price Change$ -0.02
30 Day Percent Change-28.57%
Month to Date Price Change$ -0.01
Month to Date Percent Change-16.67%
Quarter to Date Price Change$ -0.025
Quarter to Date Percent Change-33.33%
180 Day Price Change$ -0.07
180 Day Percent Change-58.33%
200 Day Price Change$ -0.065
200 Day Percent Change-56.52%
Year to Date Price Change$ -0.065
Year to Date Percent Change-56.52%

Appili Therapeutics Inc. (APLI) Key Ratios

PROFITABILITY
EBIT Margin-1,319.0%
EBITDA Margin-1,318.2%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,390,684
Revenue Per Share$ 0.011468
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-3.82
Total Debt To Equity0.17
Int Coverage-10.80
Current Ratio2.00
Leverage Ratio-3.20
Quick Ratio1.90
Long Term Debt To Capital0.14
VALUATION MEASURES
PE Ratio-0.20
Enterprise Value$ 5,741,145
Price to Sales4.3599
Price to Free Cash-0.40
PE High Last 5 Years0.00
Price To Book1.40
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-3.82
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.00
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-205.87
Return on Equity-891.35
Return on Capital-362.27

Appili Therapeutics Inc. (APLI) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEOArmand Balboni
Emplyoees8
Last AuditUE
CIK0000000000
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressNo. 21-1344 Summer Street
Suite 415
Halifax, NS B3H 0A8
Websitehttps://www.appilitherapeutics.com
Facsimile+1 902 442-4651
Telephone+1 902 442-4655
Email-
Your Recent History
TSX
APLI
Appili The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220926 17:12:55